Available Technologies

Filter

Filtered by

Results

Dysferlinopathy Compounds

Technology, Tangible Property / Case number: #22496
Mohan Viswanathan / Eric Williams / Kana Tominaga / Naoomi Tominaga / Leonard Guarente
Technology Areas: Therapeutics
Impact Areas: Healthy Living, Uncharted Frontiers
License

Targeting Dendritic Cell Lectins with Glycosylated Particles Containing TLR Ligands Facilitates Efficient Immune Responses

Technology / Case number: #24570J
Laura Kiessling / Valerie Lensch / M.G. Finn / Mohammad Murshid Alam / Robert Hincapie
Technology Areas: Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Synthetic Mucin Glycans as Antifungal Agents

Technology / Case number: #24073J
Katharina Ribbeck / Julie Takagi / Rachel Hevey
Technology Areas: Therapeutics
Impact Areas: Healthy Living
License

Synthesis of Covalent Protein Dimers that can Inhibit MYC-Driven Transcription

Technology / Case number: #23305WJ
Bradley Pentelute / Isaac Klein / Carly Schissel / Sebastian Pomplun / Andrei Ioan Loas / Jacob Rodriguez / Muhammad Jbara / Ann Boija / Susana Hawken / Charles Li / Stephen Buchwald
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living, Uncharted Frontiers
License

Targeting Lung Microbiota and its Responding Immune Pathways for Lung Cancer Treatment

Technology / Case number: #20602HRJ
Paul Blainey / Chengcheng Jin / Georgia Lagoudas / Tyler Jacks
Technology Areas: Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

RNA-Loaded Lipid Nanoparticle (LNP)

Technology, Tangible Property / Case number: #24973H
Byungji Kim / Darrell Irvine
Technology Areas: Biotechnology / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Target for Modulating Body Mass

Technology / Case number: #21326
Nikola Ivica / Yingzhong Li / Ting Dong / Jianzhu Chen
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Programmable RNA Writing with the Novel RNA-Guided RNA-Targeting CRISPR-Cas7-11 Enzyme

Technology / Case number: #24072
Omar Abudayyeh / Jonathan Gootenberg / Wenyuan Zhou / Cian Schmitt-Ulms / Alisan Kayabolen
Technology Areas: Biotechnology / Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Structure and Engineering of the Type III-E CRISPR-Cas7-11 Effector Complex

Technology / Case number: #23945J
Omar Abudayyeh / Jonathan Gootenberg / Wenyuan Zhou / Hiroshi Nishimasu / Kazuki Kato / Cian Schmitt-Ulms
Technology Areas: Biotechnology / Diagnostics / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Nanoparticle Conjugates of Highly Potent Toxins

Technology / Case number: #19222
Paiman Ghoroghchian / Ruogu Qi
Technology Areas: Biotechnology / Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Synthetic Cell/Condition-Specific Promoters and Enhancers

Technology / Case number: #18570
Timothy Lu / Lior Nissim / Ming Ru Wu
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

Transcriptional Sensor for Bile Acids in Bacteroides Thetaiotaomicron

Technology / Case number: #18573
Christopher Voigt / Mao Taketani
Technology Areas: Biotechnology / Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

Convergent and Biomimetic Enantioselective Total Synthesis of (-)-Communesin F

Technology / Case number: #18676
Mohammad Movassaghi / Stephen Lathrop / Matthew Pompeo / Wen-Tau Chang
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Identification and Application of Ketogenic Properties of Intestinal Stem Cell

Technology / Case number: #20090
George Eng / Omer Yilmaz / Chia-Wei Cheng / Fang Wang
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Functionalization of Protective Antigen by Chemical Conjugation

Technology / Case number: #20802
Bradley Pentelute / Zeyu Lu
Technology Areas: Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

DNA Virus Launched RNA Replicon System (VREP) for Prolonged and High Level Expression of Transgenes with High Precision Controls

Technology / Case number: #20866
Ron Weiss / Jacob Becraft / Jin Huh
Technology Areas: Biotechnology / Drug Delivery / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Platinum-Anthracycline Derivative Conjugates and Their Therapeutic Applications

Technology / Case number: #20922
Stephen Lippard / Omer Yilmaz / Fang Wang / Jonathan Braverman
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Intraperitoneal Injection of Nanoparticles Results in Near Perfect Localization Within Peritoneal Tumor Deposits

Technology / Case number: #19352
Xiangnan Dang / Paiman Ghoroghchian / Zhimin Tao / Angela Belcher
Technology Areas: Chemicals & Materials / Therapeutics
Impact Areas: Healthy Living
License

Systems, Methods, And Compositions For RNA-Guided RNA-Targeting CRISPR Effectors from Type III Systems

Technology / Case number: #23239
Omar Abudayyeh / Jonathan Gootenberg
Technology Areas: Biotechnology / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Novel Small Molecule Modulators of Myb-Mediated Transcription with Potential Use for Cancer Therapy

Technology / Case number: #22044
Angela Koehler / Becky Leifer / Florian Kabinger / Brice Curtin / Jasmin Kruell
Technology Areas: Biotechnology / Therapeutics
Impact Areas: Healthy Living
License

The technologies listed represent a selection of the MIT intellectual property protected by the TLO.

filtered: 174 results

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up